Huangbin Sun

Title: The Innovations of Huangbin Sun

Introduction: Huangbin Sun is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. His work focuses on creating stable solid dispersions that enhance the efficacy of therapeutic agents.

Latest Patents: Huangbin Sun holds a patent for a "Stable solid dispersion of a B-RAF kinase dimer inhibitor, methods of preparation, and uses therefor." This patent discloses a physically stable solid dispersion comprising Compound 1, which is a B-RAF kinase dimer inhibitor. The compound is characterized by its unique structure and is combined with a specific stabilizing polymer. The patent also details the method for preparing this solid dispersion and its various uses. Additionally, it includes information about the crystalline form of Compound 1.

Career Highlights: Huangbin Sun is associated with Beigene, Ltd., a leading biotechnology company focused on developing innovative medicines for cancer treatment. His work at Beigene has positioned him as a key player in the pharmaceutical industry, contributing to advancements in cancer therapies.

Collaborations: Huangbin Sun has collaborated with notable colleagues, including Guoliang Zhang and Changyou Zhou. These collaborations have fostered a productive environment for research and development, leading to significant innovations in their field.

Conclusion: Huangbin Sun's contributions to the field of pharmaceuticals, particularly through his patent on a B-RAF kinase dimer inhibitor, highlight his role as an influential inventor. His work continues to impact the development of effective cancer treatments, showcasing the importance of innovation in medicine.